Borrelia (Lyme Disease).

What does this test assess?

This method detects IgM and IgG antibodies against Borrelia burgdorferi sensu lato species from a dried blood spot, supporting the clinical diagnosis of Lyme disease.

Clinical indications include:

• Clinical diagnosis of suspected Lyme disease
• Detection of early (IgM) and late (IgG) immune response to Borrelia infection
• Screening in endemic areas following tick exposure
• Evaluation of persistent symptoms in patients with suspected late Lyme disease

Measured analytes

Analytical technique

Antibodies are detected using the EUROIMMUN enzyme-linked immunosorbent assay (ELISA) platform, adapted for the DBS matrix. The assay uses recombinant antigens from the three main pathogenic Borrelia species prevalent in Europe and North America.